Lis Boyce joined national law firm, Piper Alderman as a corporate partner specialising in the health and life sciences sector in Sydney on Monday, 1 February 2021.
Lis has a long-standing reputation as one of Australia’s leading health & life sciences lawyers, advising clients from start-up and spin-out to IPO and life as a listed company. She also advises local subsidiaries of international life sciences, healthcare, manufacturing and logistics companies, and works closely with a number of not-for-profit organisations on their governance and strategic projects.
Piper Alderman’s Managing Partner, Tony Britten-Jones, said he was delighted to welcome a partner of Lis’ calibre to the firm:
“Lis is a highly respected and leading practitioner in life sciences. Her practice is very much aligned with our existing offering and the skill, experience and relationships she has will help us continue to build on the foundations of our existing practice and deepen our relationships with key clients in line with our strategic goals.”
As Deputy Chair of AusMedtech’s National Advisory Group and a member of AusBiotech’s NSW committee, Lis has been deeply involved in the life sciences sector, including chairing the Aus Biotech task force which wrote the “Guide for Directors of Life Sciences Companies” and contributing to AusBiotech’s “Guide to Life Sciences Investing”.
Lis is ranked by Chambers & Partners Asia-Pacific for Life Sciences in Australia, recognised by Best Lawyers in Australia for Life Sciences and is a graduate of the Australian Institute of Company Directors’ Company Directors’ Course.
Commenting on her decision to join the firm, Lis said:
“I’m excited to join Piper Alderman, which is a great “fit” in mission, expertise and culture. I look forward to applying my experience and connections as a strategic contributor to the firm’s growth and to the success of the clients we serve.”
